EKSO — EKSO BIONICS HOLDINGS, INC.

Nasdaq · Industrials · Machinery · CIK 1549084 ·
Last close
$11.65
Market Cap
$41.51M
52W High
$13.50
52W Low
$7.89
ADV30
57,095
Next earnings
2026-07-27
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 2,141,000 1,074,000 -5,618,000 -6,885,000 19,668,000 3,993,000 13,928,000
Dec 2025 3,140,000 1,671,000 -4,509,000 -4,674,000 20,111,000 1,169,000 11,084,000
Sep 2025 4,227,000 2,549,000 -1,402,000 -1,421,000 21,661,000 2,722,000 11,982,000
Jun 2025 2,057,000 819,000 -3,975,000 -2,709,000 23,167,000 5,242,000 12,237,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-11,959,000
Investing CF
$-178,000
Financing CF
$8,052,000
CapEx
$-188,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-5.62
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-269,281,000
Inventory
$4,649,000
Receivables
$4,537,000
ST Investments
EBIT TTM
$-15,308,000
Pretax Income TTM
$-15,689,000
Interest Exp TTM
$381,000
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$12,799,000
EBITDA
$-11,003,000
Free Cash Flow
$-4,496,125
Enterprise Value
$44,240,080
Total Cash
$1,169,000
Total Debt
$4,644,000
Shares Out
3,563,381
Trailing EPS
$-5.11
Book Value
$2.54
ROE
-107.6%
ROA
-33.6%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 12,799,000 -13,326,000 -11,695,000 20,111,000 11,084,000 -11,801,000
Dec 2024 17,925,000 -10,460,000 -11,330,000 26,652,000 13,945,000 -9,846,000
Dec 2023 18,279,000 -15,112,000 -15,198,000 28,918,000 16,312,000 -12,054,000
Dec 2022 12,912,000 -15,556,000 -15,080,000 40,903,000 15,461,000 -14,688,000

TTM Snapshot

Revenues TTM
$11,232,000
NetIncome TTM
$-13,156,000
OpCashFlow TTM
$0
Assets (Latest)
$40,903,000
Forward EPS
$-0.19

Peers — same industry

TickerNameMarket CapLastDaily %
CVV CVD EQUIPMENT CORP $41.23M $5.94
FTEK FUEL TECH, INC. $46.12M $1.48
ZOOZ ZOOZ Strategy Ltd. $48.61M $0.30
WPRT WESTPORT FUEL SYSTEMS INC. $34.44M $1.98
QSEP QS Energy, Inc. $50.14M $0.09

News headlines (Yahoo Finance, 1h cache)

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth
2026-05-06 12:00 · Yahoo
Applied Digital (APLD) Completes Cloud, Data Center Separation, Soars 12%
2026-05-06 01:23 · Yahoo
Applied Digital Forms New Company to Boost AI-Cloud Business
2026-05-05 22:20 · Yahoo
Applied Digital Completes Separation of Cloud Business, Establishing ChronoScale as Independent Public Company
2026-05-05 12:00 · Yahoo
Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits
2026-05-03 15:11 · Yahoo
Applied Digital Reshapes AI Cloud And Debt Profile With ChronoScale Move
2026-03-29 13:03 · Yahoo
Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates
2026-02-26 13:15 · Yahoo
Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year?
2026-02-17 14:40 · Yahoo
How The Ekso Bionics Holdings Narrative Is Shifting After Q3 And A Higher Price Target
2026-02-11 19:09 · Yahoo
Construction Exoskeleton Market Trends and Supply Chain Analysis 2026-2030 & 2035 - AI-Driven Exosuits Transforming the Construction Landscape
2026-01-28 15:25 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.